Atea Pharmaceuticals (AVIR) EBT Margin (2021)
Atea Pharmaceuticals' EBT Margin history spans 1 years, with the latest figure at 63.08% for Q4 2021.
- Quarterly EBT Margin changed N/A to 63.08% in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 39.44% through Dec 2021, changed N/A year-over-year, with the annual reading at 39.44% for FY2021, 6195.0% up from the prior year.
- EBT Margin came in at 63.08% for Q4 2021, up from 67.34% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 63.08% in Q4 2021 to a low of 67.34% in Q3 2021.